Moreover, acetazolamide is known to inhibit water conduction by AQP-4 [15,16] and its use in IIH patients has a direct effect on papilledema and intracranial pressure, and significantly improves visual field function in patients with IIH [17]. This evidence concerns the gene AQP4 and optic papillitis.